ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] The current state of antibiotic drug development can at best be described as a process in transition. First, the larger pharmaceutical companies, with a few notable exceptions (e.g., Basel-headquartered Novartis), have withdrawn from major discovery efforts to identify new classes of drugs needed ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/nbt1206-1519
Permalink